Why is Transgene Biotek falling/rising?

As of 04-Jul, Transgene Biotek Ltd's stock price is currently at 4.85, reflecting an increase of 0.12, or 2.54%. The stock has shown a positive performance today, outperforming its sector by 1.7%, and has been on a consecutive gain streak for the last three days, accumulating a total return of 5.66% during this period. Over the past week, the stock has risen by 9.73%, while it has increased by 21.25% over the past month. However, it is important to note that the stock is down 28.99% year-to-date and has seen a significant decline of 44.57% over the past year. The stock's current performance is supported by rising investor participation, with a delivery volume increase of 1.33% against the five-day average, indicating growing interest among investors.
In the broader market context, while Transgene Biotek's short-term performance has been strong, it contrasts with the Sensex, which has declined by 0.74% over the past week and increased by 3.01% over the past month. This suggests that the stock's recent gains are not reflective of the overall market trend. Despite the stock's positive short-term movements, it remains significantly lower in performance compared to the benchmark over longer periods, such as year-to-date and one-year returns. The lack of specific positive or negative factors in the dashboard limits a deeper analysis of the influences on the stock's movement, but the current upward trend appears to be driven by short-term investor sentiment and trading activity.